{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:49:31Z","timestamp":1795063771077,"version":"4.10.2"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006751","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003358","name":"Gedeon Richter","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002975","name":"Dainippon Sumitomo Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009655","name":"Sunovion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006546","name":"Angelini Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006546","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007123","name":"Stanley Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007123","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017301","name":"Forest Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2314-B-182A-009-MY2"],"award-info":[{"award-number":["109-2314-B-182A-009-MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2314-B-002-150-MY3"],"award-info":[{"award-number":["109-2314-B-002-150-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 109\\u20132314-B-002\\u2013150-MY3"],"award-info":[{"award-number":["MOST 109\\u20132314-B-002\\u2013150-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004321","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.euroneuro.2022.01.112","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T16:19:38Z","timestamp":1644596378000},"page":"20-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Differences in the prophylactic effect of serum lithium levels on depression and mania in bipolar disorder: A dose-response meta-analysis"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8650-4060","authenticated-orcid":false,"given":"Chih-Wei","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Ying","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Tao","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Sung","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0548-0053","authenticated-orcid":false,"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon","family":"Stubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8890-8544","authenticated-orcid":false,"given":"Hung-Yu","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Kang","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pao-Yen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2022.01.112_bib0001","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1176\/appi.ajp.2009.09020284","article-title":"Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study","volume":"167","author":"Amsterdam","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0002","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archpsyc.57.5.481","article-title":"A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group","volume":"57","author":"Bowden","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0003","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder","volume":"64","author":"Calabrese","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0004","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1906193","article-title":"Bipolar disorder","volume":"383","author":"Carvalho","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jad.2014.03.035","article-title":"Predominant polarity as a course specifier for bipolar disorder: a systematic review","volume":"163","author":"Carvalho","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0006","article-title":"Treatment implications of predominant polarity and the polarity index: a comprehensive review","volume":"18","author":"Carvalho","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0007","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/bdi.13031","article-title":"The rebirth of lithium as the archetypal mood stabilizer","volume":"23","author":"Carvalho","year":"2021","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0008","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.smrv.2018.07.003","article-title":"Associations between sleep duration and suicidality in adolescents: a systematic review and dose-response meta-analysis","volume":"42","author":"Chiu","year":"2018","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0009","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0165-0327(83)90026-5","article-title":"Decreasing lithium dosage reduces morbidity and side-effects during prophylaxis","volume":"5","author":"Coppen","year":"1983","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0010","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1177\/0962280218773122","article-title":"One-stage dose-response meta-analysis for aggregated data","volume":"28","author":"Crippa","year":"2019","journal-title":"Stat. Methods Med. Res."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0011","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.psychres.2018.08.034","article-title":"The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: a plea for further research attention","volume":"269","author":"Fornaro","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0012","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2147\/NDT.S100846","article-title":"Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review","volume":"12","author":"Fornaro","year":"2016","journal-title":"Neuropsychiatric Disease Treatment"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0013","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1176\/appi.ajp.2019.19030228","article-title":"Lithium exposure during pregnancy and the postpartum period: a systematic review and meta-analysis of safety and efficacy outcomes","volume":"177","author":"Fornaro","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0014","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/1745017901612010142","article-title":"Does the \"Silver Bullet\" lose its shine over the time? Assessment of loss of lithium response in a preliminary sample of bipolar disorder outpatients","volume":"12","author":"Fornaro","year":"2016","journal-title":"Clin. Practice Epidemiol. Mental Health"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0015","first-page":"121","article-title":"The international college of neuro-psychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), Part 2: review, grading of the evidence, and a precise algorithm","volume":"20","author":"Fountoulakis","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0016","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJM198911303212201","article-title":"Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder","volume":"321","author":"Gelenberg","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0017","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/0269881116636545","article-title":"Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology","volume":"30","author":"Goodwin","year":"2016","journal-title":"J. Psychopharmacol. (Oxford)"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0018","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0019","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/acps.13346","article-title":"Lithium concentration and recurrence risk during maintenance treatment of bipolar disorder: multicenter cohort and meta-analysis","volume":"144","author":"Hsu","year":"2021","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0020","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/dom.14382","article-title":"The J-shaped relationship between body mass index and mortality in patients with COVID-19: a dose-response meta-analysis","volume":"23","author":"Huang","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0021","first-page":"383","article-title":"Choice of exposure scores for categorical regression in meta-analysis: a case study of a common problem","volume":"16","author":"Il'yasova","year":"2005","journal-title":"Cancer Causes Control."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0022","series-title":"Lithium in Medical Practice","first-page":"407","article-title":"Plasma lithium control with particular reference to minimum effective plasma levels","author":"Jerram","year":"1978"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0023","doi-asserted-by":"crossref","DOI":"10.1111\/bdi.12623","article-title":"Effectiveness of maintenance therapy of lithium vs other mood stabilizers in monotherapy and in combinations: a systematic review of evidence from observational studies","author":"Kessing","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0024","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1038\/s41380-020-00946-6","article-title":"Mood stabilizers and\/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials","volume":"26","author":"Kishi","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0025","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1017\/S0033291720003505","article-title":"Recurrence rates in stable bipolar disorder patients after drug discontinuation v. drug maintenance: a systematic review and meta-analysis","volume":"51","author":"Kishi","year":"2021","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0026","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/JCP.0000000000001264","article-title":"Recurrence of mania or depression among adult bipolar patients who continued using Lithium: a Single-group summary meta-analysis of randomized trials","volume":"40","author":"Kishi","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0027","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00406-005-0574-x","article-title":"Is polarity of recurrence related to serum lithium level in patients with bipolar disorder?","volume":"255","author":"Kleindienst","year":"2005","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0028","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/jamapsychiatry.2021.2130","article-title":"Examination of dosing of antipsychotic drugs for relapse prevention in patients with stable schizophrenia: a Meta-analysis","volume":"78","author":"Leucht","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0029","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1055\/s-2007-1017280","article-title":"Minimum plasma lithium levels required for effective prophylaxis in DSM III bipolar disorder: a prospective study","volume":"19","author":"Maj","year":"1986","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0004867420979353","article-title":"The 2020 royal Australian and New Zealand college of psychiatrists clinical practice guidelines for mood disorders","volume":"55","author":"Malhi","year":"2021","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0031","first-page":"1841","volume":"396","author":"McIntyre","year":"2020","journal-title":"Bipolar Disorders. Lancet"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0032","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0033","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jad.2019.04.067","article-title":"The effect of psychotropic drugs on cortical excitability and plasticity measured with transcranial magnetic stimulation: implications for psychiatric treatment","volume":"253","author":"Minzenberg","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0034","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.euroneuro.2021.08.264","article-title":"Preventing new episodes of bipolar disorder in adults: systematic review and meta-analysis of randomized controlled trials","volume":"54","author":"Nestsiarovich","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0036","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1176\/appi.ajp.2012.12060751","article-title":"Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium","volume":"170","author":"Nierenberg","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0037","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/bdi.12805","article-title":"What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD\/IGSLI Task Force on treatment with lithium","volume":"21","author":"Nolen","year":"2019","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0038","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bdi.12027","article-title":"The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144)","volume":"15","author":"Nolen","year":"2013","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0039","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1536867X0600600103","article-title":"Generalized least squares for trend estimation of summarized dose\u2013response data","volume":"6","author":"Orsini","year":"2006","journal-title":"Stata J"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/aje\/kwr265","article-title":"Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software","volume":"175","author":"Orsini","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0041","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1176\/ajp.133.5.567","article-title":"Relationship between dosage and response to lithium prophylaxis in recurrent depression","volume":"133","author":"Prien","year":"1976","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0042","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.euroneuro.2019.11.006","article-title":"Systematic review and practical guideline for the prevention and management of the renal side effects of lithium therapy","volume":"31","author":"Schoot","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0043","article-title":"Prevalence of impaired kidney function in patients with long-term lithium treatment: a systematic review and meta-analysis","author":"Schoretsanitis","year":"2021","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0044","doi-asserted-by":"crossref","DOI":"10.1186\/s40345-014-0015-8","article-title":"Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis","volume":"2","author":"Severus","year":"2014","journal-title":"Int. J. Bipolar. Disord."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0045","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/01.jcp.0000177550.13714.7a","article-title":"Is the prophylactic antidepressant efficacy of lithium in bipolar I disorder dependent on study design and lithium level?","volume":"25","author":"Severus","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0046","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1399-5618.2007.00475.x","article-title":"What is the optimal serum lithium level in the long-term treatment of bipolar disorder\u2013a review?","volume":"10","author":"Severus","year":"2008","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0047","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2165\/00003088-200241090-00002","article-title":"Lithium in bipolar disorder: can drug concentrations predict therapeutic effect?","volume":"41","author":"Sproule","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0048","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0049","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0050","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/bdi.13040","article-title":"Long-term treatment of bipolar disorder type I: a systematic and critical review of clinical guidelines with derived practice algorithms","volume":"23","author":"Verdolini","year":"2021","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0051","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1600-0447.1998.tb10089.x","article-title":"Outcome of lithium prophylaxis: a prospective follow-up of affective disorder patients assigned to high and low serum lithium levels","volume":"98","author":"Vestergaard","year":"1998","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0052","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S2215-0366(15)00505-2","article-title":"Estimating the true global burden of mental illness","volume":"3","author":"Vigo","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0053","first-page":"1323","article-title":"Determination of the optimal concentration of lithium for the prophylaxis of manic-depressive disorder","volume":"17","author":"Waters","year":"1982","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0054","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.4088\/JCP.11m06878","article-title":"Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study)","volume":"72","author":"Weisler","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.01.112_bib0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X22001213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X22001213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:29:26Z","timestamp":1778549366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X22001213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":55,"alternative-id":["S0924977X22001213"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2022.01.112","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in the prophylactic effect of serum lithium levels on depression and mania in bipolar disorder: A dose-response meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2022.01.112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}